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Abstract 26 
 27 
The objective of this study was to investigate the effect of time of first postpartum 28 
ovulation after calving on uterine involution in dairy cows with and without uterine 29 
puerperal disease. Transvaginal follicular puncture (FP) of follicles > 6 mm 30 
suppressed ovulation and development of a CL until Day 42 after calving. Fifty-three 31 
lactating Holstein Friesian cows (3.4 ± 1.2 yr old, parity 2.5 ± 1.0 [median ± mean 32 
absolute deviation]) were divided into groups based on the presence (UD+) or 33 
absence (UD–) of uterine disease and whether follicular puncture was carried out 34 
(FP+) or not (FP–). Uterine disease was defined as the occurrence of retained fetal 35 
membranes and/or metritis. This resulted in the following groups: UD–FP– (n = 15), 36 
UD–FP+ (n = 13), UD+FP– (n = 13), and UD+FP+ (n = 12). A general examination, 37 
vaginoscopy, transrectal palpation, and transrectal B-Mode sonography of the 38 
reproductive organs were conducted on Days 8, 11, 18, 25 and then every ten days 39 
until Day 65 after calving. After hormonal synchronization of ovulation (cloprostenol 40 
between Days 55 and 60 postpartum and GnRH 2 d later), cows were inseminated in 41 
the next spontaneous estrus. On average, the cows ovulated on Day 21.0 ± 6.0 (UD–42 
FP–), 50.0 ± 4.0 (UD–FP+), 16.0 ± 3.0 (UD+FP–), and 48.0 ± 2.0 (UD+FP+) 43 
postpartum. Calving-to-conception interval and first-service conception rates were 44 
not affected by FP (P > 0.05). Healthy cows with FP had smaller (P < 0.05) uterine 45 
horn and cervical diameters assessed sonographically than cows without FP. 46 
Follicular puncture reduced the prevalence of purulent vaginal discharge and uterine 47 
size assessed transrectally in UD+ cows (P < 0.05). The results showed that 48 
suppression of an early ovulation by transvaginal follicular puncture improved uterine 49 
involution in cows with and without uterine disease. 50 
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1. Introduction 55 
 56 
The puerperal period is a critical phase in the reproductive cycle of dairy cows (5). 57 
Uterine involution, which includes reduction of uterine size, regeneration of the 58 
endometrium, elimination of bacterial contamination and resumption of ovarian 59 
cyclicity occurs during this period and is a prerequisite for subsequent gestation (29). 60 
The calving-to-first ovulation interval is affected by nutrition, body condition (24), 61 
suckling (30), parity (36), and uterine disease (27,38). In healthy cows the interval to 62 
first ovulation lasts from 21 to 30 days (12,23,25). Puerperal uterine diseases may 63 
prolong the anovulatory interval by up to ten days (39). 64 
Published information on the effect of length of the postpartum anovulatory period on 65 
reproductive performance in cows is equivocal. Some studies have shown that 66 
shortening of the postpartum anovulatory period is associated with improved fertility 67 
(3,6,13,37), whereas others reported reduced fertility (34) or did not find a positive 68 
effect (23). The latter phenomenon was explained by immunosuppression and 69 
muscle relaxation attributable to progesterone (P4) from the corpus luteum during the 70 
early postpartum period (1,2). Furthermore, early ovulation may be associated with 71 
luteal persistence if accompanied by bacterial uterine contamination (4,16), possibly 72 
related to preferential accumulation of luteotropic PGE, rather than luteolytic PGF, in 73 
cows with an inflamed endometrium (28).  74 
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Previous experimental studies on the effect of the postpartum anovulatory interval on 75 
fertility of dairy cows have used estrogens or GnRH analogues (deslorelin) for 76 
postpartum suppression of ovulation (11,18,31-33). Whether and to what degree 77 
uterine effects were caused indirectly by the suppression of ovulation or directly by 78 
the experimentally used hormones is not known. Estrogens have a positive effect on 79 
myometrial contractility and enhance uterine immune response (14,22,31). GnRH 80 
analogues also enhance uterine motility (7). One study on the effect of the timing of 81 
the first postpartum ovulation on uterine involution included cows with and without 82 
puerperal uterine diseases but results were not analyzed by the health status of the 83 
cows (33).  84 
Transvaginal follicular puncture provides an experimental method of postpartum 85 
suppression of ovarian activity without the use of hormones. This technique is well 86 
tolerated by cows; new cyclic ovarian activity starts as early as 4 to 7 d after follicle 87 
aspiration, and negative effects on ovarian structure and function are minimal 88 
(8,19,35). 89 
The aim of this study was to investigate the effect of postpartum suppression of 90 
ovulation achieved by repeated transvaginal follicular puncture on uterine involution 91 
in healthy dairy cows and in cows with postpartum uterine disease.  92 
 93 
2. Material and Methods 94 
 95 
2.1. Animals 96 
 97 
This study was carried out at the Research Farm of the University of Veterinary 98 
Medicine Hannover, Germany, between February 2009 and July 2010 and was 99 
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approved by, and in accordance with, German legislation on animal rights and 100 
welfare (33.9-42502-04-08/1592). The herd consisted of 90 milking Holstein Friesian 101 
cows and the rolling herd average was 10 100 kg of milk per lactation. The cows 102 
were housed in a freestall barn and fed a total mixed ration supplemented with 103 
concentrate based on milk yield. Fresh water was available ad libitum.  104 
 105 
2.2. Study design 106 
 107 
Between Days 4 and 21 after calving (Day 0 = day of calving) the animals were 108 
divided into the following two groups: cows with no uterine disease (UD–) and cows 109 
with uterine disease (UD+). Uterine disease was defined as the occurrence of 110 
retained fetal membranes (membranes not shed within 24 h after calving) and/or 111 
metritis. Metritis was diagnosed by transrectal palpation and vaginal examination 112 
according to Sheldon et al. (26). Cows of both groups were randomly subdivided into 113 
two subgroups: in the first, ovulation was suppressed by repeated transvaginal 114 
follicular puncture (FP) until Day 42 (group FP+) and in the second, FP was not 115 
carried out (group FP–). This resulted in the four groups designated UD–FP–, UD–116 
FP+, UD+FP–, and UD+FP+. Cows from the FP– groups that did not ovulate by Day 117 
42 and cows from the FP+ groups that ovulated or had a progesterone (P4) 118 
concentration > 1.0 ng/ml before Day 42 were excluded from the study. Ovulation 119 
was diagnosed retrospectively when a CL (> 20 mm) was detected 120 
ultrasonographically. Cows with other diseases (lameness, digestive disorders, 121 
mastitis) during the study period were also excluded. 122 
Cows underwent a general examination, vaginoscopy and transrectal palpation, and 123 
B-Mode sonography of the reproductive tract on Days 8, 11, 18, 25 and then every 124 
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ten days until Day 65. For synchronization of ovulation all cows received 125 
intramuscular injections of 0.5 mg cloprostenol (Estrumate®, Intervet, 126 
Unterschleißheim, Germany), between Days 55 and 60, and 0.01 mg GnRH 127 
(buserelin; Receptal®, Intervet, Unterschleißheim, Germany) 2 d later. AI was 128 
performed in the following spontaneously occurring estrus. Pregnancy diagnosis was 129 
conducted sonographically 35 to 50 d after AI. Detection of an embryo with a 130 
heartbeat was taken as evidence for pregnancy. Calving-to-first ovulation interval, 131 
calving-to-conception interval, and first-service conception rate were calculated for 132 
evaluation of reproductive performance. 133 
 134 
2.3. Transrectal palpation and vaginoscopy 135 
 136 
Transrectal palpation served to assess uterine size and contractility. Uterine size was 137 
classified according to Grunert (10) and each cow was allocated to one of six 138 
categories: uterus retractable and horn diameter < 2 cm (1), 2 to 5 cm (2) or > 5 cm 139 
(3), uterus not retractable but greater curvature palpable (4), uterus not retractable 140 
and greater curvature incompletely palpable (5), and uterus not retractable and 141 
greater curvature poorly outlined (6). Uterine contractility was classified as absent 142 
(0), moderate (1), or strong (2). 143 
A tube speculum and flashlight were used for vaginoscopy. During the early 144 
postpartum period (≤ 21 d postpartum), vaginoscopy was used to classify cows as 145 
UD+ and UD- according to Sheldon et al. (26). After Day 21 postpartum, the vaginal 146 
discharge was categorized as absent (0), clear mucus (1), mucus containing flecks of 147 
pus (2), up to 50% pus (3), or more than 50% pus (4; from Sheldon et al (26), 148 
modified). 149 
6 
 
  Revised  
 150 
2.4. Ultrasonography 151 
 152 
Transrectal B-Mode sonography was carried out with a Powervision SSA-370 153 
ultrasound machine (Toshiba Co., Tokyo, Japan) equipped with a 7.5-MHz 154 
microconvex transducer. Cross-sectional images of the cervix and uterine horns were 155 
obtained by placing the transducer accordingly. The middle part of the cervix was 156 
imaged and the uterine horns were evaluated approximately 2 cm cranial the 157 
bifurcation. Three images were taken at each position, frozen, and stored on a 158 
Magneto Optical Disc (Sony, Tokyo, Japan). Analysis was done off-line on a personal 159 
computer using FixFoto® software (Version 2.74, Joachim Koopmann Software, 160 
Wrestedt-Stederdorf, Germany). The best images were selected for measurement of 161 
the cervical and uterine horn diameters. The former was defined as vertical 162 
dimension from serosa to serosa through the center of the organ. Because the cross-163 
sectional image of the uterine horns was often oval, diameter was calculated as the 164 
mean of the maximum height and width of the endometrium. The ovaries were 165 
examined for follicles and CLs. 166 
 167 
2.5. Transvaginal follicular aspiration 168 
 169 
At the start of the study all follicles ≥ 10 mm were punctured twice a week. However, 170 
because several cows ovulated and had to be excluded from the study (see 3.), the 171 
FP interval was reduced to two or three days and all follicles ≥ 6 mm were punctured. 172 
Epidural anesthesia using 3 mL procaine hydrochloride (Procasel® 2%, Selectavet, 173 
Weyarn-Holzolling, Germany) was administered and the ovaries identified using a 174 
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Logiq Book XP ultrasound machine (General Electrics Medical Systems, Jiangsu, P. 175 
R. China) equipped with a 7.5-MHz microconvex transducer, which was inserted 176 
vaginally. The transducer and the aspiration needle (Sterican® 0.90 x 50 mm, B. 177 
Braun Melsungen AG, Melsungen, Germany) were encased in a PVC carrier, which 178 
was protected by a latex cover (MAPA®, Zeven, Germany) filled with ultrasound gel 179 
(Waldeck GmbH & Co KG, Münster, Germany). The ovaries were fixed transrectally 180 
by hand, the needle inserted into the follicles to be aspirated, and the fluid aspirated 181 
using a syringe and plastic tubing (17). 182 
 183 
2.6. Steroid hormones 184 
 185 
Blood samples were collected weekly from a jugular vein into EDTA tubes and 186 
placed on ice after collection. After centrifugation (2000 x g, 20 min at 4°C), plasma 187 
was separated and stored at -20°C until analysis. The plasma P4 concentration was 188 
measured using a commercial coat-a-count radioimmunoassay according to the 189 
manufacturer’s instructions (Progesterone Coat-a-Count, TKPG1, Siemens Medical 190 
Diagnostics, CA, USA). The analytical sensitivity was 0.02 ng/ml, the intra-assay 191 
coefficient of variation (CV) was 4.0%, and the inter-assay CV was 7.6%. Total 192 
estrogen (E) concentration was determined after ether extraction with a direct 193 
enzyme-immunoassay on microtiter plates using a secondary-antibody coating 194 
technique and horseradish peroxidase as the enzyme label (15,21). The antiserum 195 
used was raised against 17β-estradiol hemisuccinate (cross reactivity 17β-estradiol 196 
100%, estrone 100%, 17α-estradiol 70%). The 17β-estradiol hemisuccinate 197 
horseradish peroxidase was used as steroid-enzyme conjugate. The minimal 198 
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detectable concentration was 8 pg/ml. Recovery ranged from 84.6 to 96.2%, the 199 
intra-assay CV was 13.2%, and the inter-assay CV was19.7%. 200 
 201 
2.7. Statistical analysis 202 
 203 
Statistical analyses were carried out using the Statistical Analysis System (SAS 204 
Institute, Cary, North Carolina). The Shapiro-Wilk test was used to test for normality 205 
of the distribution of all variables. Because not all variables were normally distributed, 206 
median and median absolute deviation (MAD) values were given. Differences 207 
between groups were analyzed using the non-parametric Wilcoxon´s rank sum test 208 
(PROC NPAR1WAY). The two variables time of ovulation and length of first cycle 209 
were compared between the UD– and UD+ groups, and all other variables were only 210 
compared between the FP– and FP+ groups. The effect of day postpartum on 211 
variables was determined using the Friedman two-way ANOVA (PROC FREQ). 212 
Differences in values between Days 4 and 25 and between Days 25 and 65 within 213 
groups were analyzed using the Wilcoxon´s signed rank test (PROC UNIVARIATE) 214 
and differences between groups were analyzed using a combination of Wilcoxon´s 215 
signed rank test (PROC UNIVARIATE) and Wilcoxon´s rank sum test (PROC 216 
NPAR1WAY). The χ2-test of homogeneity was used to compare categorical data 217 
between groups (PROC FREQ). Differences were considered significant at P < 0.05. 218 
 219 
3. Results 220 
 221 
A total of 83 cows were included in this study; six were excluded because of 222 
displaced abomasum (n = 2), mastitis (n = 2), severe lameness (n = 1), and 223 
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reticuloperitonitis (n = 1). Fifteen cows of the FP+ group ovulated before Day 42, and 224 
three cows without sonographic evidence of ovulation had P4 concentrations greater 225 
than 1.0 ng/ml in the first 42 d. Six cows of the FP– group did not ovulate in the first 226 
42 d (UD–, n = 2; UD+, n = 4). This resulted in the following group sizes: UD–FP–, 227 
n = 15; UD–FP+, n = 13; UD+FP–, n = 13; UD+FP+, n = 12. The cows were 228 
3.4 ± 1.2 yr old, parity was 2.5 ± 1.0, and BCS was 2.75 ± 0.25. The groups did not 229 
differ (P > 0.05) with respect to these variables. 230 
Table 1 shows time of first ovulation, first-cycle length, calving-to-conception interval, 231 
and first-service conception rate for each group. The UD+FP– and UD–FP– groups 232 
differed with respect to first-cycle length (P < 0.05). 233 
 234 
Table 1 here 235 
 236 
3.1. Transrectal palpation and vaginoscopy 237 
 238 
Uterine size was affected by time (P < 0.0001, Fig. 1); the score decreased 239 
(P < 0.05) by 67% (UD–FP–), 60% (UD–FP+ and UD+FP+), and 40% (UD+FP–) in 240 
the first 25 d. Thereafter until Day 65 it declined further (P < 0.05) by 17% (UD–FP–), 241 
20% (UD–FP+ and UD+FP+) and 40% (UD+FP–). There was a trend (P = 0.07) in 242 
the UD+ group for a smaller decrease in uterine size between Days 25 and 65 in FP+ 243 
cows compared with FP– cows. In the UD+ group there was an effect of FP on 244 
uterine size (P < 0.05). On Day 4, UD–FP– cows had greater (P < 0.05) uterine size 245 
than UD–FP+ cows. On Days 11, 18, 25 and 35, UD+FP– cows had larger (P < 0.05) 246 
uterine size than UD+FP+ cows. Uterine contractility was affected by time in the UD–247 
FP+ and UD+FP– cows (P < 0.05), but not by FP within groups (P > 0.05).  248 
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 249 
Figure 1 here 250 
 251 
The incidence of vaginal discharge was affected by time in UD+ cows (P < 0.05; 252 
Table 2) but not in UD– cows (P > 0.05). There was an effect of FP in UD+ cows 253 
(P < 0.05); on Day 35, more UD+FP– cows (P < 0.05) had vaginal discharge 254 
compared with UD+FP+ cows. 255 
 256 
Table 2 here 257 
 258 
3.2. Ultrasonographic findings 259 
 260 
Cervical diameter was affected by time in all groups (P < 0.0001; Fig. 2). Between 261 
Days 8 and 25, the diameter decreased (P < 0.05) by 33% (UD–FP– and UD+FP+), 262 
38% (UD–FP+), and 31% (UD+FP–). After Day 25, it decreased (P < 0.05) by 263 
another 24% (UD–FP–), 10% (UD–FP+), 12% (UD+FP–), and 16% (UD+FP+). In 264 
group UD– there was a trend for a smaller decrease (P = 0.07) in cervical diameter 265 
between Days 25 and 65 in FP+ cows compared with FP– cows. For the UD– 266 
animals an effect of FP could be noticed (P < 0.05). On Days 25, 35, and 65, UD– 267 
cows with FP had a smaller (P < 0.05) cervical diameter than cows without FP. In 268 
UD+ cows, the same effect occurred on Day 65 (P < 0.05). 269 
 270 
Figure 2 here 271 
 272 
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Diameter of both horns was affected by time in all groups (P < 0.0001; Fig. 3). By 273 
Day 25, the diameter of the previously pregnant/non-pregnant horns decreased 274 
(P < 0.05) by 55%/35% (UD–FP–), 55%/45% (UD–FP+), 57%/43% (UD+FP–), and 275 
52%/42% (UD+FP+). After Day 25, diameters decreased (P < 0.05) by 8%/8% (UD–276 
FP–) and 7%/10% (UD+FP–) or the decrease was merely numerical (3%/0%, UD–277 
FP+; 7%/8%, UD+FP+; P > 0.05). In the UD– group, FP+ cows had a smaller 278 
decrease in horn diameter than FP– cows between Days 25 and 65 (P < 0.05). Over 279 
the whole examination period UTD-values were not affected by FP within UD groups 280 
(P > 0.05). Only on Day 18 the diameter of both uterine horns were larger (P < 0.05) 281 
in the UD–FP–– cows compared with UD–FP+ cows (Fig. 3). 282 
 283 
Figure 3 here 284 
 285 
Five UD+FP– cows, but no cows of other groups, developed a persistent CL (38%; 286 
P < 0.05). 287 
 288 
3.3. Steroid hormone concentrations 289 
 290 
Plasma P4 concentrations were affected by time in all groups (P < 0.0001; Fig. 4). In 291 
UD–FP– cows they exceeded 1.0 ng/ml between Days 21 and 28 and in the UD+FP– 292 
cows between Days 14 and 21. In FP+ cows a P4-increase above 1.0 ng/ml occurred 293 
between Days 49 and 56. In FP– cows the P4 concentrations decreased below 294 
1.0 ng/ml between Days 49 and 56. FP group affected P4 concentration in UD– and 295 
UD+ cows (P < 0.05 and P < 0.001). In the UD– group, FP– cows had higher 296 
(P < 0.05) P4 concentration than FP+ cows on Days 35 and 42. The UD+FP– cows 297 
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had higher (P < 0.05) P4 concentrations on Days 21, 28, 35, 42, and 49 than 298 
UD+FP+ cows. 299 
 300 
Figure 4 here 301 
 302 
There were no effects of time and FP on total E concentration (P > 0.05). On Day 21, 303 
UD–FP– cows had higher and on Day 49 had lower (P < 0.05) E concentrations than 304 
UD–FP+ cows (Fig. 5).  305 
 306 
Figure 5 here 307 
 308 
4. Discussion 309 
 310 
Suppression of ovulation by transvaginal FP had a positive effect on uterine 311 
involution in healthy cows as well as in cows with uterine disease. Healthy cows with 312 
FP had smaller cervical diameter and a faster reduction of uterine horn diameters 313 
than cows without FP, and in cows with postpartum disease, FP was associated with 314 
smaller uterine size and lower incidence of vaginal discharge compared with cows 315 
without FP. This supports the idea that postpartum suppression of ovulation, and 316 
thus secretion of progesterone, enhances reduction in uterine size and the 317 
elimination of inflammation and bacterial contamination, especially in cows with 318 
uterine disease. Suppression of early postpartum ovulation in cows using slow-319 
release deslorelin implants also resulted in smaller cervical and uterine diameters 320 
compared with untreated controls (31,33). In contrast to those studies, uterine 321 
contractility was not affected by the time of the first ovulation in our experiment. 322 
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Progesterone has a relaxing effect on the uterus (1,22) and therefore we expected 323 
FP to be associated with increased uterine contractility. In cows treated with 324 
deslorelin, the effect on uterine and cervical size, seems to be more pronounced than 325 
in the present study (31,33). A possible reason for this can be the intrinsic positive 326 
inotropic effect of deslorelin on the uterus (7); cows treated with this drug had 327 
increased uterine tone compared with untreated cows (31,33). Another possible 328 
explanation for the discrepancy between studies can be that intravaginal 329 
manipulations and epidural anesthesia during FP had an adverse effect on uterine 330 
involution.  331 
Purulent vaginal discharge was more common in UD+FP– cows than in UD+FP+ 332 
cows. This could be associated with the immunosuppressive effect of progesterone 333 
(2,14) resulting in impaired elimination of bacterial contamination and inflammation in 334 
the postpartum period. Purulent vaginal discharge was uncommon in healthy cows 335 
as expected, and unlike cows treated with deslorelin (31), we did not observe an 336 
increase in vaginal discharge in FP+ cows compared with FP– cows. However, the 337 
definition of healthy cows may have differed between studies because previously 338 
(31), only cows with retained placenta, dystocia, and stillbirth were excluded. 339 
Interestingly, in healthy cows, FP was associated with a significant reduction in 340 
uterine horn diameter only on Day 18. In addition to the positive influence of FP, 341 
elevated estrogen concentrations in the FP– cows could have contributed to the 342 
difference. High levels of estrogens during estrus lead to uterine edema and thus to 343 
an increase in uterine size (12,20). Possible differences in concentrations of total 344 
estrogens between FP+ and FP– animals, might have been missed in the present 345 
study, because of the low frequency of blood sampling. 346 
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After Day 25, the uterine horn diameter measured sonographically decreased only 347 
minimally (Fig. 3), whereas the score for uterine size assessed transrectally 348 
continued to decrease (Fig. 1). During transrectal palpation, uterine length was 349 
estimated in addition to uterine diameter, and uterine diameter decreases more 350 
quickly than uterine length (9). Because of the length of the uterus, overall uterine 351 
size may be estimated to be larger via transrectal palpation than by merely 352 
measuring the cornual cross-sectional diameter near the bifurcation. When the uterus 353 
is enlarged by fluid accumulation, which tends to collect toward the tips of the horns, 354 
measurement of the cornual diameter is likely to underestimate the overall uterine 355 
size.  356 
All analyzed FP+ cows had progesterone concentrations below 1.0 ng/ml until Day 357 
49. Three FP+ cows were excluded from the study because of progesterone 358 
concentrations exceeding 1 ng/ml within the first 42 d after calving even though 359 
ovulation was not detected sonographically. Based on the results of other studies 360 
(19,35), we assumed that these cows generated luteal tissue from residual tissue of 361 
punctured follicles. This luteal tissue does not reach the size of a cyclic CL but is 362 
active endocrinologically and produces near-physiologic mid-cycle progesterone 363 
concentrations (19). In agreement with earlier studies (19,35), FP+ cows ovulated 6 364 
to 8 d after the last follicle aspiration. This procedure interferes with the ovarian 365 
follicular dynamics and follicular growth and is followed by rapid resumption of cyclic 366 
activity. FP removes the inhibitory effects of estradiol and inhibin on FSH, and the 367 
initiation of a new cohort of follicles and the growth of a dominant follicle are 368 
enhanced (19). In contrast, the first ovulation after suppression of ovarian activity 369 
with deslorelin from Days 7 to 35 occurred 12 d after removal of the GnRH implant 370 
(18). 371 
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Cows not undergoing FP ovulated and had progesterone concentrations greater than 372 
1.0 ng/ml in the first three weeks. Persistent CLs only occurred in UD+FP– cows, 373 
which was in agreement with previous reports that early postpartum ovulations 374 
accompanied by uterine infection are prone to lead to luteal persistence (16,28). 375 
Inducing cyclic activity in the early postpartum period with GnRH has been proposed 376 
for improvement of fertility in dairy herds (2,16), although this practice was 377 
associated with an increased incidence of pyometra (4). Taken together, these 378 
findings advocate against early induction of ovulation in cows with postpartum uterine 379 
disease. 380 
There was no significant effect of time of first postpartum ovulation on reproductive 381 
performance. This was in agreement with an earlier report (23) but in contrast to 382 
another study, in which early ovulation was associated with a reduced fertility in 383 
multiparous cows (34). However, FP+ cows had numerically longer calving-to-384 
conception intervals, similar to cows that received continuous deslorelin treatment for 385 
28 d to delay ovulation. In the latter study, the effect could have been due to delayed 386 
onset of cyclic activity because the time from first ovulation to conception did not 387 
differ between the treated and untreated cows (18). Furthermore, pregnancy rates 388 
did not differ either, which does not support an adverse effect of an extended 389 
postpartum anovulatory period on reproductive performance (18), and in the present 390 
study, conception rate to first service was slightly increased numerically in UD–FP+ 391 
cows compared with UD–FP– cows. However numbers of cows in this study were not 392 
sufficient to draw meaningful conclusions with respect to reproductive performance.  393 
In conclusion, suppression of early ovulation and luteal activity by transvaginal FP 394 
improves uterine involution in healthy cows as well as in cows with uterine disease. 395 
Because of a high incidence of luteal persistence after early ovulation in cows with 396 
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uterine disease, early hormonal induction of cyclic activity is not recommended in 397 
these cows. 398 
 399 
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Tables 531 
 532 
Table 1: Time of first ovulation, first-cycle length, calving-to-conception interval, and 533 
first-service conception rate in cows with and without uterine disease (UD+/UD–) and 534 
with and without follicle aspiration (FP+/FP–) (medians ± MAD).  535 
 536 
 UD–FP– (n=15) 
UD–FP+ 
(n=13) 
UD+FP– 
(n=13) 
UD+FP+ 
(n=12) 
Time of first ovulation 
(days postpartum) 21.0 ± 6.0 50.0 ± 4.0 16.0 ± 3.0 48.0 ± 2.0 
First-cycle length (days) 19.5 ± 2.0a  25.0 ± 5.0b  
Calving-to-conception 
interval (days) 107.0 ± 26.0 120.0 ± 27.0 119.0 ± 22.0 135.5 ± 23.0 
First-service conception 
rate (%) 40 46 39 25 
 537 
Values with letters (a, b) indicate differences between groups UD–FP– and UD+FP– 538 
(P<0.05). 539 
540 
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Table 2: Relative and absolute incidence of purulent vaginal discharge in cows with 541 
and without uterine disease (UD+/UD–) and with and without follicle aspiration 542 
(FP+/FP–) at different examination times postpartum 543 
 Days postpartum 
Group 25 35 45 55 65 
UD–FP– 7.1% (1/14) 
6.7% 
(1/15) 
7.1% 
(1/14) 
7.1% 
(1/14) 
20.0% 
(3/15) 
UD–FP+ 0% (0/13) 
7.7% 
(1/13) 
0% 
(0/13) 
0% 
(0/13) 
7.7% 
(1/13) 
UD+FP– 53.8% (7/13) 
38.5%a 
(5/13) 
46.2% 
(6/13) 
16.7% 
(2/12) 
15.4% 
(2/13) 
UD+FP+ 25.0% (3/12) 
0%b 
(0/12) 
25.0% 
(3/12) 
8.3% 
(1/12) 
0% 
(0/11) 
 544 
Values with different letters (a, b) indicate differences between groups UD+FP– and 545 
UD+FP+ (P<0.05). 546 
 547 
548 
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Figure legends 549 
 550 
Figure 1: Changes of uterine size (score 1-6) in the first 65 days postpartum in dairy 551 
cows with and without uterine diseases (UD+/UD–) and with and without follicular 552 
puncture (FP+/FP–). Values are medians ± median absolute deviation. Values with 553 
different letters (a, b) indicate differences between groups UD–FP– and UD–FP+ as 554 
well as between groups UD+FP– and UD+FP+ (P < 0.05). 555 
 556 
Figure 2: Changes of cervical diameter in the first 65 days postpartum in dairy cows 557 
with and without uterine diseases (UD+/UD–) and withand without follicular puncture 558 
(FP+/FP–). Values are medians ± median absolute deviation. Values with different 559 
letters (a, b) indicate differences between groups UD–FP– and UD–FP+ (P < 0.05). 560 
 561 
Figure 3: Changes of diameter of the previously pregnant uterine horn in the first 562 
65 days postpartum in dairy cows with and without uterine diseases (UD+/UD–) and 563 
with and without follicular puncture (FP+/FP–). Values are medians ± median 564 
absolute deviation. Values with different letters (a, b) indicate differences between 565 
groups UD–FP– and UD–FP+ (P < 0.05). At individual measuring times values with 566 
different letters are different (P < 0.05). 567 
 568 
Figure 4: Changes of plasma progesterone concentration in the first 56 days 569 
postpartum in dairy cows with and without uterine diseases (UD+/UD–) and with and 570 
without follicular puncture (FP+/FP–). Values are medians ± median absolute 571 
deviation. Values with different letters (a, b) indicate differences between groups UD–572 
FP– and UD–FP+ as well as between groups UD+FP– and UD+FP+ (P < 0.05). 573 
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 574 
Figure 5: Changes of total estrogen concentration in the first 56 days postpartum in 575 
dairy cows with and without uterine disease (UD+/UD–) and with and without 576 
follicular puncture (FP+/FP–). Values are medians ± median absolute deviation. 577 
Values with different letters (a, b) indicate differences between groups UD–FP– and 578 
UD–FP+ (P < 0.05). 579 
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